Is a complete PVLA research report available?

No complete published report is available for Palvella Therapeutics, Inc. (PVLA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Palvella Therapeutics, Inc. (PVLA)

NASDAQ: PVLA · USD

$143

-0.24 (-0.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PVLA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2B
Net income (ttm)	-49.3M
EPS (ttm)	-$4.19
Shares out	14.3M
Volume	133,993
Price target	$230	+61.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -49.3M
EPS (ttm): -$4.19
Market cap: 2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PVLA indicators

Market & fundamental data

Available fields

164

Groups with data

Currency

USD

Showing 164 of 164 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001742961
Company name	Palvella Therapeutics, Inc.
Country	United States
Country code	US
Cusip	697947109
Employees	29
Enterprise value	$1.8B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US6979471090
Last refreshed	2026-07-30
Market cap	$2B
Market cap category	Mid-Cap
Price	$143
Price currency	USD
Sector	Healthcare
Sector PE	45.63
Sector PE Fwd	24.38
Sic	2834
Symbol	PVLA
Website	https://palvellatx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.41%
P/B ratio	8.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-49.3M
Net Income Growth Years	0%
Profit Per Employee	$-1.7M
ROA	-16.6
ROCE	-17.9
ROE	-34.25
ROIC	-17.73

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	257.97%
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$263.8M
Cash	$261.9M
Current Assets	$263.2M
Current Liabilities	$9.1M
Debt	$20.4M
Debt Equity	$0.09
Equity	$232.3M
Interest Coverage	-6.86
Liabilities	$31.4M
Long Term Assets	$528,000
Long Term Liabilities	$22.3M
Net Cash	$241.5M
Net Cash By Market Cap	$11.81
Net Cash Growth	286.54%
Net Debt Equity	$-1.04
Tangible Book Value	$232.3M
Tangible Book Value Per Share	$16.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	28.88
Net Working Capital	$-7.5M
Quick ratio	28.73
Working Capital	$254.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-159.41%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	257.66%
200-day SMA	108.8
50-day SMA	128.1
50-day SMA vs 200-day SMA	50over200
All Time High	161.4
All Time High Change	-11.64%
All Time High Date	2026-06-30
All Time Low	11.17
All Time Low Change	1,176.63%
All Time Low Date	2024-12-30
ATR	10.51
Beta1y	0.38
Beta2y	0.04
Ch YTD	36.24
High	148.9
High52	161.4
High52 Date	2026-06-30
High52ch	-11.64%
Low	139.4
Low52	34.57
Low52 Date	2025-08-01
Low52ch	312.5%
Ma50ch	11.3%
Premarket Change Percent	-0.38
Premarket Price	$142
Premarket Volume	1,596
Price vs 200-day SMA	31.09%
RSI	52.3
RSI Monthly	78.56
RSI Weekly	60.69
Sharpe ratio	1.88x
Sortino ratio	3.24
Total Return	-159.41%
Tr YTD	36.24
Tr1m	-3.79%
Tr1w	0.3%
Tr3m	13.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	15
Analyst Count Top	13
Analyst Price Target Top	$233
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.16
Operating Income	$-45.6M
Price target	$230
Price Target Change	$61.01
Price Target Change Top	$63.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,577,476%
Float Percent	66.78%
Shares Insiders	8.42%
Shares Institutions	80.65%
Shares Out	14,342,844
Shares Qo Q	10.2%
Shares Yo Y	159.41%
Short Float	22.73%
Short Ratio	7.11
Short Shares	15.18

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted OCF	-37,785,000
Average Volume	238,238.6x
Bv Per Share	16.23
Ch1m	-3.79
Ch1w	0.3
Ch1y	257.7
Ch3m	13.21
Ch6m	81.17
Change	-0.17%
Change From Open	-2.54
Close	142.8
Days Gap	2.44
Dollar Volume	19,107,401.8
Earnings Date	2026-08-04
Earnings Time	bmo
EBIT	$-45.6M
EBITDA	$-45.6M
EPS	$-4.19
F Score	2
Financing CF	215,273,000
Fiscal Year End	December
Founded	2,015
Investing CF	-55,440,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Ma150	116.6
Ma150ch	22.26%
Ma20	144.2
Ma20ch	-1.09%
Net CF	130,768,000
Next Earnings Date	2026-08-04
Open	146.3
Optionable	Yes
Position In Range	34
Post Close	142.6
Postmarket Change Percent	-0.03
Postmarket Price	$143
Ppne	528,000
Pre Close	142.8
Price Date	2026-07-29
Ptbv Ratio	8.8
Relative Volume	0.56x
Share Based Comp	8,683,000
Tr6m	81.17%
Us State	Pennsylvania
Volume	133,993

Palvella Therapeutics, Inc. (PVLA)

Coverage state: Market snapshot only — no published research

Generate the first PVLA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · PVLA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PVLA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PVLA

Frequently asked questions